Zimmer Biomet Holdings, Inc.
Zimmer Biomet Holdings
ZBH · NYSE
Healthcare
Catalog as of September 15, 2026. Not a live market feed.
- Fiscal Year
- 2025
- Revenue
- $8.2B
- Assets
- $23.1B
- SEC filing
- DEF 14A
- Filed
- April 1, 2026
Executive Compensation
Compensation reported for Zimmer Biomet Holdings’ named executive officers, including salary, stock awards, incentive compensation, other compensation, and total compensation.
Ivan Tornos
Chairman, President and CEO
$16.1M
Reported total
- Salary
- $1,281,846
- Stock awards
- $12,000,101
- Incentives
- $2,420,767
- Option awards
- $0
- Other
- $403,836
Jehanzeb Noor
SVP, Chief Strategy, Business Development
$7.9M
Reported total
- Salary
- $683,000
- Stock awards
- $5,100,212
- Incentives
- $1,846,422
- Option awards
- $0
- Other
- $244,574
Suketu Upadhyay
CFO and EVP - Finance, Operations and Supply Chain
$6.2M
Reported total
- Salary
- $906,780
- Stock awards
- $4,000,104
- Incentives
- $1,141,636
- Option awards
- $0
- Other
- $163,284
Kevin Thornal
Group President, Global
$6.2M
Reported total
- Salary
- $405,385
- Stock awards
- $5,300,085
- Incentives
- $505,275
- Option awards
- $0
- Other
- $0
Wilfred van Zuilen
Group President, EMEA
$4.1M
Reported total
- Salary
- $743,149
- Stock awards
- $2,000,052
- Incentives
- $730,333
- Option awards
- $0
- Other
- $665,875
Ivan Tornos
Chairman, President and CEO
$16.1M
Reported total · FY2025 · SCT Total as filed
Source: DEF 14A Summary Compensation Table, filed April 1, 2026.
- Salary
- $1.3M
- Stock Awards
- $12M
- Incentives
- $2.4M
- Other
- $404K
Historical Compensation
Ivan Tornos total compensation, fiscal years 2023–2025.
| Fiscal Year | Salary | Stock Awards | Total Compensation |
|---|---|---|---|
| 2025 | $1,281,846 | $12,000,101 | $16,106,550 |
| 2024 | $1,236,923 | $11,750,148 | $14,992,867 |
| 2023 | $968,702 | $7,472,584 | $10,191,476 |
Named Executive Officers
Ivan Tornos
Chairman, President and CEO
Zimmer Biomet Holdings · ZBH
$16.1M
FY 2025 · DEF 14A
Suketu Upadhyay
CFO and EVP - Finance, Operations and Supply Chain
Zimmer Biomet Holdings · ZBH
$6.2M
FY 2025 · DEF 14A
Kevin Thornal
Group President, Global
Zimmer Biomet Holdings · ZBH
$6.2M
FY 2025 · DEF 14A
Jehanzeb Noor
SVP, Chief Strategy, Business Development
Zimmer Biomet Holdings · ZBH
$7.9M
FY 2025 · DEF 14A
Wilfred van Zuilen
Group President, EMEA
Zimmer Biomet Holdings · ZBH
$4.1M
FY 2025 · DEF 14A
Source information
- Company
- Zimmer Biomet Holdings, Inc.
- Ticker
- ZBH · NYSE
- Filing type
- DEF 14A
- Fiscal year
- 2025
- Filing date
- April 1, 2026
- SEC accession number
- 0001193125-26-135661
Source: U.S. Securities and Exchange Commission, DEF 14A Summary Compensation Table. View SEC filing
Related Companies
Johnson & Johnson
JNJ · NYSE
Joaquin Duato
Chairman/CEO
$32.8M
FY 2025 reported total
View company
UnitedHealth
UnitedHealth Group Incorporated
UNH · NYSE
Stephen Hemsley
Chief Executive Officer
$60.9M
FY 2025 reported total
View company
AbbVie
AbbVie Inc.
ABBV · NYSE
Robert A. Michael
Chairman Of The Board And Chief Executive Officer
$32.5M
FY 2025 reported total
View company
Abbott
Abbott Laboratories
ABT · NYSE
Robert B. Ford
Chairman Of The Board And Chief Executive Officer
$24.2M
FY 2025 reported total
View company